搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Cure Today
2 天
Second Cancer Risk Heightened After Appendiceal Adenocarcinoma Diagnosis
Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...
11 天
on MSN
Gut Check! 4 Types of Stomach Cancer You Need to Know About
By staying abreast of signs and risk factors, such as persistent indigestion, unexplained weight loss, or discomfort in the ...
ascopubs.org
3 天
Prevalence of FGFR2b Protein Overexpression in Advanced Gastric Cancers During Prescreening ...
Fig 2. Representative FGFR2b membranous staining at different intensities. Gastric cancers. (A) Gastric adenocarcinoma, surgical resection from primary lesion. (B) Tumor cells are negative for FGFR2b.
Targeted Oncology
3 天
Nivolumab Plus Chemo Improves OS in Chinese Patients With Advanced Gastric/GEJ Cancer
The phase 3 CheckMate 649 trial showed that nivolumab plus chemotherapy significantly improved long-term overall survival in Chinese patients with advanced gastric, gastroesophageal junction, and ...
BioSpace
2 天
Merck’s Keytruda Combo Fails to Extend Survival in Phase III GI Cancer
The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...
FiercePharma
2 天
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈